Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Estrogen Receptor and/or Progesterone Receptor Positive|HER2/Neu Negative|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
Interventions: DRUG: Fulvestrant|OTHER: Laboratory Biomarker Analysis|DRUG: Palbociclib|OTHER: Questionnaire Administration|DRUG: Aromatase Inhibitors
Sponsor: Ohio State University Comprehensive Cancer Center